Further reading

User Rating: / 0
PoorBest 
Reports - EMCDDA Report on the risk assessment of PMMA

Drug Abuse

Other EMCDDA publications in the field of new synthetic drugs and implementation of the joint action

EMCDDA Insights series

New trends in synthetic drugs in the European Union: epidemiology
and demand-reduction responses
Insights series No 1
Published: 1997
ISBN: 92-9168-030-3
Price: EUR 20.50

Implementation of the joint action

Report on the risk assessment of GHB in the framework of the joint action on new
synthetic drugs
Published: 2002
ISBN: 92-9168-122-9
Price: Free

Report on the risk assessment of ketamine in the framework of the joint action on
new synthetic drugs
Published: 2002
ISBN: 92-9168-123-7
Price: Free

Report on the risk assessment of 4-MTA in the framework of the joint action on new
synthetic drugs
Published: 1999
ISBN: 92-9168-087-7
Price: Free

Report on the risk assessment of MBDB in the framework of the joint action
on new synthetic drugs
Published: 1999
ISBN: 92-9168-063-X
Price: Free

Guidelines for the risk assessment of new synthetic drugs
Published: 1999
ISBN: 92-9168-061-3
Price: Free

 

Show Other Articles Of This Author